Outcomes of Anti-Spike Monoclonal Antibody Therapy in Pregnant Women with Mild to Moderate COVID-19

Bright P. Thilagar, Aditya K. Ghosh, Jerome Nguyen, Regan N. Theiler, Myra J. Wick, Ryan T. Hurt, Raymund R. Razonable, Ravindra Ganesh
doi: https://doi.org/10.1101/2021.11.27.21266942

Article Information

doi 
https://doi.org/10.1101/2021.11.27.21266942
History 
  • November 28, 2021.
Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.

Author Information

  1. Bright P. Thilagar, M.D.1,
  2. Aditya K. Ghosh, M.D.1,
  3. Jerome Nguyen, B.S.2,
  4. Regan N. Theiler, M.D., Ph.D.3,
  5. Myra J. Wick, M.D., Ph.D.3,
  6. Ryan T. Hurt, M.D., Ph. D.1,
  7. Raymund R. Razonable, M.D.4 and
  8. Ravindra Ganesh, M.B.B.S., M.D.1,*
  1. 1Division of General Internal Medicine, Mayo Clinic, Rochester, MN
  2. 2Department of Nursing, Mayo Clinic, Rochester, MN
  3. 3Department of Obstetrics and Gynecology, Mayo Clinic, Rochester, MN
  4. 4Division of Infectious Diseases, Mayo Clinic, Rochester, MN
  1. ↵*Corresponding Author:
    Ravindra Ganesh M.B.B.S., M.D., 200 1st Street SW, Rochester, MN 55905, Ganesh.ravindra{at}mayo.edu, 507-284-2511
Back to top
Posted November 28, 2021.
Download PDF
Data/Code
Email
Outcomes of Anti-Spike Monoclonal Antibody Therapy in Pregnant Women with Mild to Moderate COVID-19
Bright P. Thilagar, Aditya K. Ghosh, Jerome Nguyen, Regan N. Theiler, Myra J. Wick, Ryan T. Hurt, Raymund R. Razonable, Ravindra Ganesh
medRxiv 2021.11.27.21266942; doi: https://doi.org/10.1101/2021.11.27.21266942
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area